Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding
Launched by CENTRE FOR GLOBAL PUBLIC HEALTH PAKISTAN · Aug 28, 2023
Trial Information
Current as of August 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a special computer program called MATCH-AI can help find people with tuberculosis (TB) more effectively during screening events. The trial compares two different ways of choosing locations for these screenings: one using predictions from the MATCH-AI software and the other relying on the knowledge and experience of the staff running the camps. The goal is to see if using the AI tool can lead to finding more cases of TB in the community.
To be eligible for this trial, participants need to be 15 years or older and can include anyone who has previously had TB. Unfortunately, children under 15 and pregnant women cannot participate. If you join the trial, you can expect to take part in a screening camp where you will be tested for TB, and your participation will help researchers understand if using AI can improve TB detection in the future. This study is currently recruiting participants, so if you or someone you know meets the eligibility criteria, it could be a valuable opportunity to contribute to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All individuals \>15 years of age presenting to camp sites
- • Individuals with previous history of TB disease
- Exclusion Criteria:
- • Children and adolescents \<15 years of age
- • Pregnant women
About Centre For Global Public Health Pakistan
The Centre for Global Public Health Pakistan is a leading research organization dedicated to advancing public health initiatives through innovative clinical trials and comprehensive health studies. With a focus on addressing pressing health challenges in Pakistan and beyond, the Centre collaborates with local and international partners to generate evidence-based solutions that enhance health outcomes. Its multidisciplinary team of experts employs rigorous methodologies to ensure the integrity and impact of its research, ultimately contributing to policy development and the improvement of public health systems. Through its commitment to ethical practices and community engagement, the Centre aims to foster sustainable health advancements that benefit diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, , Pakistan
Patients applied
Trial Officials
Faran Emmanuel
Principal Investigator
Centre for Global Public Health Pakistan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported